This site is intended for health professionals only

Covid-19 Primary Care Resources


Reducing Covid-19 risk in your diabetic patient population



Evidenced based approaches to risk reduction, and who to prioritise for review

This information is sourced from the The Centre for Evidence-Based Medicine (CEBM), the Primary Care Diabetes Society (PCDS) and NHSE:

Suggested approaches for reducing risk of Covid-19 infection and severity:

  • General guidance on risk reduction, including social distancing and hand washing
  • Good glycaemic control may help in reducing the risk of infection and severity
  • Ensure adequate supplies of both medications and testing equipment, especially for those requiring ketone monitoring (but do not stockpile)
  • More frequent blood glucose monitoring (in people who self-monitor)
  • Influenza and pneumonia vaccinations as offered
  • Management of coexisting heart or kidney disease

Who to prioritise for review

The PCDS suggest the following practice-generated searches to consider:

  • Due/overdue reviews/ previous nonattenders
  • Poor control (HbA1c ≥75 mmol/mol; BP or lipid targets not met; high CVD risk)
  • On insulin or sulphonylurea (hypo risk assessment)
  • Comorbidities/vulnerable
  • Recent diagnosis – tight control urgent to ensure legacy effect

They also suggest that opportunistic reviews should be done:

  • Post-hospital discharge
  • Self-referral (e.g. patient wishing to have review)
  • Diabetes complication (e.g. hypoglycaemia, foot problem)